NMN Nicotinamide Mononucleotide 250 mg by ForestLeaf — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size

30 Servings

Non-Nutrient/Non-Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

Nicotinamide Mononucleotide

250 mg

📊 Market median: 250.0mg (1 products) 📚 6 studies (Tier A: 0, B: 2)

This product: 250mg

Other Ingredients

Vegetable Cellulose Vegetable Stearate Silicon Dioxide Microcrystalline Cellulose

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (90% of products) Nutrient (2% of products)

Target Groups

Vegetarian Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, adults take 2-8 capsules daily. Can be taken morning or night, with or without food, or as directed by your healthcare professional. Taking smaller doses multiple times a day is most effective.

⚠️ Warnings & Precautions

Caution: Keep out of reach of children.

If you are pregnant, nursing, or taking any prescription medicine, consult your physician before taking this product.

🧪 Formulation Notes

NMN Nicotinamide Mononucleotide helps improve health and longevity by raising NAD+ levels responsible for energy production, healthy brain functions, and metabolism.

Helps raise NAD+ levels Helps cellular renewal & resilience Promotes healthy aging & longevity Increase energy & brain functions

Vegetarian friendly

Made in the USA

GMP compliant / FDA registered UL certified facility

Non GMO Dairy, gluten, & egg free

Tested for absorption Pharmaceutical grade NAD+ & longevity support

NMN Nicotinamide Mononucleotide 250 mg per 2 capsules

Additional Information

Age better with NMN.

Store in a cool, dry place.

Product Details

UPC / SKU 7 60412 26760 5

DSLD Entry Date 2022-01-22

Product Type Non-Nutrient/Non-Botanical

Form Capsule

Brand ForestLeaf

DSLD ID 259124

Data Updated 2026-04-11

Research Evidence

8 Research Sources

54 Avg Quality Score

4 Rct

2 Meta Analysis

2 Clinical Trial

B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials

Meta Analysis Critical reviews in food science and nutrition 2025

PubMed DOI

B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study

Rct GeroScience 2024

PubMed DOI

C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.

Rct Science (New York, N.Y.)

PubMed DOI

C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.

Rct GeroScience

PubMed DOI

C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials

Meta Analysis Current diabetes reports 2024

PubMed DOI

C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial

Rct Scientific reports 2023

PubMed DOI

C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.

Clinical Trial ClinicalTrials.gov 2021

ClinicalTrials.gov

C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function

Clinical Trial ClinicalTrials.gov 2017

ClinicalTrials.gov

View all evidence for Nmn →